Announcements Trials
Browse Landscape

Phase

Phase 1/2 3Phase 3 1

Status

Recruiting 4Active not recruiting 3Not yet recruiting 1Enrolling by invitation 1Completed 1

Sponsor Class

INDUSTRY 4

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 4

Conditions

Breast Neoplasms 220Neoplasms 192Carcinoma, Non-Small-Cell Lung 185Colorectal Neoplasms 129Prostatic Neoplasms 119Lung Neoplasms 107Neoplasm Metastasis 91Multiple Myeloma 89Ovarian Neoplasms 85Pancreatic Neoplasms 78Squamous Cell Carcinoma of Head and Neck 71Leukemia, Myeloid, Acute 70Melanoma 61Stomach Neoplasms 56Recurrence 51Endometrial Neoplasms 50Brain Neoplasms 46Lymphoma 45Carcinoma, Renal Cell 45Carcinoma, Hepatocellular 45Glioblastoma 44Urinary Bladder Neoplasms 43Triple Negative Breast Neoplasms 43Precursor Cell Lymphoblastic Leukemia-Lymphoma 42Hematologic Neoplasms 40Esophageal Neoplasms 39Lymphoma, Large B-Cell, Diffuse 37Leukemia, Lymphocytic, Chronic, B-Cell 37Head and Neck Neoplasms 37Lymphoma, Non-Hodgkin 36

Interventions

Docetaxel 3Prednisone 2olaparib 1fludrocortisone acetate 1enzalutamide 1cabazitaxel 1abiraterone 1Dexamethasone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Recruiting × Prostatic Neoplasms, Castration-Resistant × 30 days × Clear all
NCT06353386 2026-05-26

MK-5684-01A

Merck Sharp & Dohme LLC

Phase 1/2 Recruiting
220 enrolled
Genitourinary

Prostatic Neoplasms, Castration-Resistant

NCT06863272 2026-05-15

IDeate-Prostate02

Merck Sharp & Dohme LLC

Phase 1/2 Recruiting
360 enrolled
Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms, Castration-Resistant

NCT07225946 2026-05-11

KLK2-PASenger

Janssen Research & Development, LLC

Phase 3 Recruiting
800 enrolled
Genitourinary

Prostatic Neoplasms, Castration-Resistant

NCT04868604 2026-05-06

SECuRE

Clarity Pharmaceuticals Ltd

Phase 1/2 Recruiting
54 enrolled
Genitourinary

Prostatic Neoplasms, Castration-Resistant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡